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Background: It is unknown whether previously reported disparities for acute myocardial infarction (AMI) by race
and sex have declined over time.
Methods: We used Medicare Part A administrative data files for 1992 to 2010 to evaluate changes in per-capita
hospitalization rates for AMI, rates of revascularization (percutaneous coronary intervention (PCI) and coronary artery
bypass grafting (CABG)), and 30-day mortality for four distinct patient subcohorts: black women; black men; white
women; and white men, adjusted for age, comorbidities and year using logistic regression.
Results: The study sample consisted of 4,045,267 AMI admissions between the years 1992 and 2010 (166,660 black
women; 116,201 black men; 1,870,816 white women; 1,891,590 white men). AMI hospitalization rates differed
significantly in 1992 to 1993 among black women (61.6 hospitalizations per 10,000 Medicare enrollees), black men
(73.2 hospitalizations), white women (72.0 hospitalizations) and white men (113.2 hospitalizations) (P <0.0001).
By 2009 to 2010 AMI hospitalization rates had declined substantially in all cohorts but disparities remained with
significantly lower hospitalization rates among women and blacks compared to men and whites, respectively
(P <0.0001). In multivariable-adjusted analyses, despite narrowing of the differences between cohorts over time,
disparities in AMI hospitalization rates by race and sex remained statistically significant in 2009 to 2010 (P <0.001).
In 1992 to 1993 and 2009 to 2010, rates of PCI within 30-days of AMI differed significantly among black women
(8.6% in 1992 to 1993; 24.2% in 2009 to 2010), black men (10.4% and 32.6%), white women (12.8% and 30.5%),
and white men (16.1% and 40.7%) (P <0.0001). In multivariable-adjusted analyses, racial disparities in procedure
utilization appeared somewhat larger and sex-based disparities remained significant. Unadjusted 30-day mortality
after AMI in 1992 to 1993 for black women, black men, white women and white men was 20.4%, 17.9%, 23.1%
and 19.5%, respectively (P <0.0001); in 2009 to 2010 mortality was 17.1%, 15.3%, 18.2% and 16.2%, respectively
(P <0.0001). In adjusted analyses, racial differences in mortality declined over time but differences by sex (higher
mortality for women) persisted.
Conclusions: Disparities in AMI have declined modestly, but remain a problem, particularly with respect to patient sex.
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More than two decades of research has demonstrated
significant disparities in the management of patients
with acute myocardial infarction (AMI) based upon pa-
tient sex and race in both the United States (US) and
Europe [1-5]. Reports from the US Institute of Medicine
(IOM) and the European Union have called for providers
and policymakers to confront and eliminate socioeco-
nomic and racial and ethnic disparities in health care
[6,7]. The World Health Organization has described the
social determinants of health that lead to health inequi-
ties [8]. The US Affordable Care Act (ACA) established
a dedicated office to reduce disparities [9].
While reduction of race- and sex-based disparities has
been an international priority for decades, relatively few
longitudinal studies have assessed the success of disparity
reduction efforts. Moreover, most of the available studies
were relatively short in duration (that is, 5 to 10 years)
and few focused comprehensively on AMI [1,3]. In 2005,
Jha et al. reported no decline in racial disparities for nine
surgical procedures during the 1990s [10], but did not
study disparities in AMI-associated hospitalization or
mortality and this study has not been updated with con-
temporary data. The case fatality rate was consistently
higher among Maori and Pacific Islands people than in
Europeans in New Zealand for each age group and both
sexes [5].
The overarching objective of our analysis was to com-
prehensively examine long-term trends in AMI disparities
by patient race (black and white) and sex (male and
female). In particular, we were interested in examining
longitudinal differences in AMI-associated: 1) hospitali-
zation rates; 2) utilization of revascularization procedures;
and 3) mortality. In aggregate we felt that these three mea-
sures could comprehensively evaluate the full spectrum of
AMI care from the underlying burden of cardiovascular
disease (hospitalization rate), to processes of care (revas-
cularization) and outcomes (mortality).
Methods
Data
We linked two US Medicare Provider Analysis and
Review (MedPAR) Part A data files (one running from
1991 to 2005 and the second from 2006 to 2010) to
identify fee-for-service beneficiaries hospitalized with
AMI using International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) code, 410.xx.
The MedPAR files contain administrative data for all fee-
for-service Medicare enrollees hospitalized in US hospitals
including: demographics (age, sex, race/ethnicity); ICD-9-
CM codes for diagnoses and procedures; admission source
(for example, emergency department or transfer from out-
side hospital); admission and discharge dates; discharge
disposition (for example, home, nursing home, transfer toanother acute-care hospital, dead); and death occurring up
to three-years after discharge. The MedPAR files also
include each patient’s unique Medicare beneficiary num-
ber allowing for tracking of patients transferred between
hospitals.
We applied several inclusion and exclusion criteria
[see Additional file 1] to generate our final analytic
cohort. We began by identifying all Non-Hispanic white
or black patients hospitalized with an AMI during our
study period. We focused our analysis on blacks and
whites because the black/white racial designation has
traditionally been more accurate than other racial designa-
tions and the number of patients of ‘other’ race/ethnicity
categories were relatively small, particularly during the
early 1990s [11].
We identified a ‘new’ AMI by limiting our analysis to
each patient’s first AMI hospitalization during a given
one-year period by excluding index hospitalizations with
prior AMI during the 12-months ‘look back’ preceding
the index hospitalization. To implement the ‘look back’
we excluded patients <66 years of age at the time of
their AMI and those lacking a full 12-months of Med-
PAR data preceding their AMI hospitalization; of neces-
sity we excluded all patients hospitalized in 1991 and
2006 in order to allow us to apply the ‘look back’. We
excluded all AMI admissions occurring in 2006 because
a lack of consistent patient identification numbers across
our two MedPAR files precluded us from linking patients
across the two data sets. To be consistent with prior stud-
ies focusing on AMI [12-14], we excluded patients: 1)
enrolled in Medicare HMOs; 2) with a primary diagnoses
of 410.X2 (indicating the subsequent episode of care for
AMI); 3) patients discharged alive within one day of
admission not against medical advice, as such patients
likely represent miscoding of AMI. We also excluded
AMI admissions after 1 December 2005 for the 1991 to
2005 data file and after 1 December 2010 for the 2006 to
2010 data file to ensure a 30-day follow-up window for
each admission.
Study outcomes
We sought to evaluate changes in AMI disparities using
an array of complementary measures, including hospi-
talization rates, receipt of revascularization procedures
among those hospitalized and mortality [12-14]. Each
measure was assessed in four discrete patient cohorts:
black women, black men, white women, and white men.
Revascularization included the receipt of three com-
plementary cardiac procedures: 1) coronary angiography
(with or without percutaneous coronary intervention
(PCI); ICD-9-CM codes 37.21, 37.22, 37.23, 88.55, 88.56,
88.57); 2) PCI (ICD-9-CM codes 36.01, 36.02, 36.03,
36.04, 36.05, 36.06, 36.07,36.09, 00.66); and 3) coronary
artery bypass surgery (CABG; ICD-9-CM codes 36.10,
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We assessed receipt of each procedure at three different
time-points: 1) during the index hospitalization (that is, at
the admitting hospital); 2) during the index admission but
after transfer from the admitting hospital to a second
facility; and 3) within 30 days of AMI admission (which
included procedures performed at the admitting hospital,
after transfer, or during a subsequent readmission). Pa-
tients who underwent multiple procedures (for example,
angiography plus CABG) were included in the counts for
each. If a patient had more than one of the same pro-
cedure (for example, two PCIs within 30 days), we only
counted the first procedure. We examined unadjusted and
adjusted mortality within 30 days of AMI admission using
methods described below.
Statistical analysis
First, we compared the demographic characteristics and
prevalence of key comorbid conditions by race and gen-
der across the study period. We used analysis of variance
(ANOVA) for comparisons of continuous variables and
the chi-squared test for categorical variables. For simpli-
city, the study period was collapsed into two-year study
increments (for example, 1992 to 1993, 1994 to 1995,
and so on). Comorbid illnesses coded during the index
admission were identified using algorithms developed by
Elixhauser et al. [15].
Second, we compared unadjusted and standardized
hospitalization rates for each of our four patient cohorts
(black women, black men, white women and white
men). AMI hospitalization rates were calculated as the
number of AMI hospitalizations during a defined period
of time in a given cohort (for example, 1992 to 1993) di-
vided by the number of fee-for-service Medicare enrol-
lees in that cohort during that period (for example, 1992
to 1993). We conducted comparisons across patient
cohorts for a given time-period (for example, black women
versus white women in 1992 to 1993) as well as longitu-
dinal changes (for example, black women versus white
women over the full study period) using statistical and
graphical methods. We used analogous methods to com-
pare differences in the utilization of cardiac procedures
(catheterization, PCI and CABG) across patient cohorts
(for example, black women compared to white women
during a fixed time-period (1992 to 1993)) as well as to
compare longitudinal changes over time.
Third, we examined trends in unadjusted and risk-
adjusted 30-day mortality using hierarchical generalized
linear models. Our models were based upon models de-
veloped by the US Centers for Medicare and Medicaid
Services and adjusted for patient demographics and
comorbidities and accounted for clustering of patients
within hospitals [16]. For 30-day mortality, rates were
adjusted for age, year, location of MI, unstable angina,chronic atherosclerosis, cardiopulmonary-respiratory fail-
ure and shock, valvular heart disease, hypertension, stroke,
cerebrovascular disease, renal failure, COPD, pneumonia,
diabetes, protein-calorie malnutrition, dementia, hemiple-
gia, paraplegia, paralysis, functional disability, peripheral
vascular disease, metastatic cancer, trauma in last year,
major psychiatric disorders, chronic liver disease, history
of PCI, history of CABG and history of heart failure.
Finally, we conducted an array of sensitivity analyses.
First, we repeated our analyses of procedure utilization
using an endpoint of 30-day revascularization (PCI or
CABG) in place of our focus on individual procedures.
Second, we repeated our evaluations of procedure utili-
zation using models that adjusted for patient age and
comorbidities and accounted for clustering of patients
within hospitals; these models allowed us to examine
whether differences in utilization might be explained by
differences in patient comorbidity and/or differences in
the hospitals where each patient cohort received care.
Third, we repeated our analyses without applying the one-
year look-back, which allowed us to include patients from
1991 and 2006 in our analyses. Fourth, in order to explore
differences in the timing of revascularization, we exam-
ined the proportion of patients who received a procedure
during the index hospitalization, after transfer to another
acute care hospital, and during a separate hospital admis-
sion but within 30-days of the index admission in each of
our four patient cohorts. All sensitivity analyses and
model details are available by request. All analyses were
performed using SAS Version 9.2 (Cary, NC, USA). The




Our study consisted of 4,045,267 AMI admissions between
1992 and 2010 [see Additional file 1] of which 166,660 ad-
missions were black women, 116,201 black men, 1,870,816
white women and 1,891,590 were white men. Black and
white women hospitalized with AMI were consistently
older than black and white men (Table 1). Among each of
the four patient cohorts, age increased by approximately
three-years over the study period (Table 1).
AMI hospitalization rates
The per-capita hospitalization rate for AMI (number of
hospitalizations during a specific year/number of Medicare
enrollees in that specific patient group) differed markedly
across the four study cohorts (Table 1 and Figure 1A),
although there was evidence that the disparities narrowed
over time. In particular during the early 1990s, white men
had a higher hospitalization rate and white women a lower
hospitalization rate (P <0.001). Despite narrowing of the
differences between cohorts over time, disparities in AMI
Table 1 Characteristics of black and white men and women hospitalized with acute myocardial infarction (AMI)
Black women Black men White women White men
Hospitalizations, number (rate per 10,000 Medicare enrollees)a
1992-1993 16237 (61.6) 11958 (73.2) 219273 (72.0) 228751 (113.2)
1994-1995 17774 (63.4) 12889 (75.6) 227347 (72.4) 237520 (112.9)
1996-1997 18541 (64.9) 13351 (77.3) 228918 (72.5) 235828 (110.3)
1998-1999 19562 (67.3) 13167 (75.0) 226734 (71.5) 226984 (104.5)
2000-2001 21100 (70.5) 14091 (77.5) 231992 (72.6) 226802 (102.4)
2002-2003 21918 (71.7) 14595 (77.8) 228463 (71.5) 223957 (99.3)
2004-2005b 18276 (59.3) 12743 (65.7) 190021 (59.9) 187818 (81.5)
2007-2008 17043 (49.3) 11961 (54.3) 169446 (49.9) 170004 (67.2)
2009-2010 16209 (43.1) 11446 (46.7) 148622 (41.0) 153926 (55.6)
Age, mean (standard deviation)
1992-1993 77.1 (7.6) 75.1 (6.8) 78.4 (7.4) 75.5 (6.7)
1994-1995 77.3 (7.7) 75.3 (6.9) 78.7 (7.5) 75.8 (6.8)
1996-1997 77.8 (7.8) 75.7 (7.1) 79.4 (7.6) 76.4 (7.0)
1998-1999 78.6 (8.0) 76.1 (7.2) 80.1 (7.7) 77.1 (7.1)
2000-2001 79.0 (8.2) 76.5 (7.4) 80.6 (7.8) 77.5 (7.3)
2002-2003 79.2 (8.3) 76.4 (7.5) 80.9 (7.9) 77.7 (7.4)
2004-2005 79.7 (8.3) 76.6 (7.5) 81.2 (8.0) 78.1 (7.5)
2007-2008 79.8 (8.7) 76.5 (7.7) 81.5 (8.3) 78.1 (7.9)
2009-2010 79.7 (8.7) 76.3 (7.8) 81.6 (8.4) 78.1 (8.1)
Comorbidity, number (%)c
Diabetes
1992-1993 5671 (34.9) 2855 (23.9) 50955 (23.2) 44725 (19.6)
1994-1995 6975 (39.2) 3648 (28.3) 58780 (25.9) 53720 (22.6)
1996-1997 7700 (41.5) 4004 (30.0) 60433 (26.4) 56631 (24.0)
1998-1999 7993 (40.9) 4146 (31.5) 60627 (26.7) 57138 (25.2)
2000-2001 8639 (40.9) 4608 (33.7) 61893 (26.7) 59138 (26.1)
2002-2003 8646 (39.5) 4815 (33.0) 59646 (26.1) 58803 (26.3)
2004-2005 7021 (38.4) 4171 (32.7) 48017 (25.3) 48774 (26.0)
2007-2008 6262 (36.7) 3791 (31.7) 40832 (24.1) 43512 (25.6)
2009-2010 5867 (36.2) 3589 (31.4) 35738 (24.1) 39389 (25.6)
Congestive heart failure, number (%)c
1992-1993 7662 (47.2) 4895 (40.9) 98207 (44.8) 86088 (37.6)
1994-1995 8433 (47.4) 5403 (41.9) 103382 (45.5) 89728 (37.8)
1996-1997 9149 (49.3) 5928 (44.4) 105829 (46.2) 91840 (38.9)
1998-1999 9883 (50.5) 5897 (44.8) 106226 (46.8) 89515 (39.4)
2000-2001 10501 (49.8) 6335 (45.0) 107129 (46.2) 88753 (39.1)
2002-2003 10892 (49.7) 6565 (45.0) 107208 (46.9) 89274 (39.9)
2004-2005 9375 (51.3) 5775 (45.3) 91500 (48.2) 77046 (41.0)
2007-2008 7989 (46.9) 5189 (43.4) 75421 (44.5) 63959 (37.6)
2009-2010 7439 (45.9) 4817 (42.1) 64552 (43.4) 56955 (37.0)
Obesity, number (%)c
1992-1993 375 (2.3) 101 (0.8) 3888 (1.8) 2752 (1.2)
1994-1995 609 (3.4) 176 (1.4) 5458 (2.4) 3899 (1.6)
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Figure 1 Adjusted hospitalization rates for AMI (A) and 30-day all-cause mortality after admission for AMI (B). Y-axis shows adjusted AMI
hospitalization per 10,000 Medicare enrollees; rates were adjusted for age and year (A). For 30-day all-cause mortality, rates were adjusted for age,
year, location of MI, unstable angina, chronic atherosclerosis, cardiopulmonary-respiratory failure and shock, valvular heart disease, hypertension,
stroke, cerebrovascular disease, renal failure, COPD, pneumonia, diabetes, protein-calorie malnutrition, dementia, hemiplegia, paraplegia, paralysis,
functional disability, peripheral vascular disease, metastatic cancer, trauma in last year, major psychiatric disorders, chronic liver disease, history
of PCI, history of CABG and history of heart failure (B). AMI, acute myocardial infarction; CABG, coronary artery bypass surgery; COPD, chronic
obstructive pulmonary disease; PCI, percutaneous coronary intervention.
Table 1 Characteristics of black and white men and women hospitalized with acute myocardial infarction (AMI)
(Continued)
1996-1997 696 (3.8) 190 (1.4) 6194 (2.7) 4695 (2.0)
1998-1999 701 (3.6) 227 (1.7) 6172 (2.7) 4873 (2.2)
2000-2001 825 (3.9) 257 (1.8) 6540 (2.8) 5322 (2.4)
2002-2003 954 (4.4) 298 (2.0) 6528 (2.9) 5820 (2.6)
2004-2005 834 (4.6) 286 (2.2) 5860 (3.1) 5410 (2.9)
2007-2008 819 (4.8) 313 (2.6) 5478 (3.2) 5802 (3.4)
2009-2010 864 (5.3) 353 (3.1) 5329 (3.6) 6009 (3.9)
aThe denominator is all traditional Medicare enrollees in each stratum, that is, black female, black male, white female, and white male; bpatients from calendar
year 2006 were excluded as detailed in the Methods section; cThe denominator is AMI patients in each stratum, that is, black female, black male, white female,
and white male.
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significant in 2009 to 2010 (P <0.001). Viewed from an
alternate perspective, each cohort experienced significant
decreases in AMI hospitalization rates between 1992 to
1993 and 2009 to 2010 (P <0.01 for each cohort over time).
Procedure utilization
Unadjusted rates of all procedures (coronary angiog-
raphy, PCI and CABG) within 30 days of AMI admission
were lower for blacks compared to whites and women
compared to men throughout the study period (Table 2
and Figures 2A, B, and C). For example, in 1992 to 1993
29.0% of black women and 36.5% of black men under-
went coronary angiography (with or without PCI) within
30 days of AMI admission as compared to 34.3% of
white women and 46.7% of white men (P <0.0001). Like-
wise, in 2009 to 2010, 5.1% of black women and 8.3% of
black men received CABG within 30 days of AMI
admission compared to 5.9% of white women and 11.6%
of white men (P <0.0001). Viewed longitudinally, all pa-
tient cohorts saw an approximately 20% rise in the per-
centage of patients who received coronary angiography
within 30 days of AMI admission over the study period
(Table 2 and Figures 2A, B, and C). In addition, the pro-
portion of these procedures that were performed during
the index admission increased over time for all patient
cohorts [see Additional files 2, 3 and 4].
In analyses that adjusted for patient age and comor-
bidity [see Additional file 5] and additionally accounting
for clustering of patients within hospitals [see Additional
file 6], results were somewhat different. In particular, we
found that the lower procedure utilization in blacks as
compared to whites was largely eliminated after account-
ing for differences in age and comorbidity [see Additional
file 5] although disparities by sex (lower procedure uti-
lization among women as compared to men) persisted. In
analyses that also accounted for clustering of patients
within hospitals, racial disparities in procedure utilization
appeared somewhat larger and sex-based disparities re-
mained significant [see Additional file 6].
Mortality
Unadjusted mortality within 30 days of admission was
lower for blacks than for whites and for men than for
women throughout the study period (Table 3), although
differences appeared to decline over time. For example,
in 1992 to 1993, the 30-day mortality rate after index
AMI was lower in black men compared to white men
(17.9% versus 19.5%; P ≤0.0001) and in black women com-
pared to white women (20.4% versus 23.1%; P <0.0001).
By 2009 to 2010, absolute differences between groups had
narrowed, but remained significant (Table 3). In analyses
that adjusted for differences in demographics and comor-
bidity (Figure 1B), racial differences in mortality declinedover time but differences by sex (higher mortality for
women) persisted. Viewed from a different perspec-
tive 30-day mortality after AMI decreased significantly
(P <0.0001) within each cohort over the study period.
Discussion
In a longitudinal analysis of US Medicare beneficiaries
hospitalized with AMI between 1992 and 2010, we report
a number of important trends in disparities. We found
that AMI hospitalization rates declined substantially for
all patient groups. We also found that differences in
hospitalization rates in blacks and whites and men and
women have narrowed over time, but disparities persist.
Utilization of interventional procedures after AMI has in-
creased over time, but disparities persist with both women
and blacks being significantly less likely to receive most
procedures. Lastly, 30-day mortality following an AMI has
declined over time for all patient groups, but remains sig-
nificantly higher for women compared to men. Several
findings merit further discussion.
First, we found declines in overall hospitalization rates
for AMI among all four of our study cohorts (black
women, black men, white women, and white men). While
there are several studies reporting changes over time in
AMI mortality or quality of AMI care [17-19], there are
fewer studies of long-term trends in AMI hospitalization
rates, with somewhat contradictory results. Chen and
Krumholz examined trends in AMI hospitalization among
Medicare beneficiaries between 2002 and 2007 and noted
an approximately 20% decline in hospitalization rates [20];
they also found evidence of higher AMI hospitalization
rates among men compared to women and white men as
compared to black men. Similarly, Talbott et al. reported a
20% decline in AMI hospitalization rates using the
Centers for Disease Control (CDC) data [21]. Alternatively,
data show declines in cardiovascular disease mortality
over time without corresponding reductions in AMI hos-
pitalization rates [22]. Our findings are particularly in-
triguing when viewed through the lens of increasingly
sensitive diagnostic tests for AMI (that is, serum troponin)
that would be expected to increase AMI diagnosis and
hospitalization rates [23]. In a nationwide Danish study,
the standardized incidence rate per 100,000 people de-
creased in the 25-year period, 1984 to 2008, by 37% for
women (from 209 to 131) and by 48% for men (from 410
to 213) [24].
Our finding of differential hospitalization rates by race
and sex is noteworthy and merits brief comment. It is
possible that the lower hospitalization rates truly represent
lower population-based AMI risk among blacks (compared
to whites) and women (compared to men). However, an
array of epidemiological data suggests a higher burden
of cardiovascular disease among blacks making this sce-
nario unlikely [25,26]. An alternative and more ominous
Table 2 Percentage of black and white men and women who underwent selected procedures within 30 days of admission
for AMI
Black women Black men White women White men
Coronary angiography, number (%)
Number (%) who underwent the procedure within 30 days of admissiona
1992-1993 4707 (29.0) 4362 (36.5) 75134 (34.3) 106829 (46.7)
1994-1995 6169 (34.7) 5391 (41.8) 89097 (39.2) 123998 (52.2)
1996-1997 7101 (38.3) 6086 (45.6) 98228 (42.9) 131268 (55.7)
1998-1999 7563 (38.7) 6209 (47.2) 99993 (44.1) 128880 (56.8)
2000-2001 8565 (40.6) 6955 (49.4) 107484 (46.3) 134706 (59.4)
2002-2003 9623 (43.9) 7757 (53.2) 112046 (49.0) 139416 (62.3)
2004-2005 8356 (45.7) 7168 (56.3) 97082 (51.1) 120720 (64.3)
2007-2008 7799 (45.8) 6883 (57.6) 87771 (51.8) 110588 (65.1)
2009-2010 7867 (48.5) 6768 (59.1) 78727 (53.0) 102085 (66.3)
Among those who underwent angiography, number (%) who received their angiography during the index admissionb
1992-1993 3456 (73.4) 3193 (73.2) 46938 (62.5) 68346 (64.0)
1994-1995 4544 (73.7) 4013 (74.4) 55723 (62.5) 80312 (64.8)
1996-1997 5260 (74.1) 4500 (73.9) 63176 (64.3) 86863 (66.2)
1998-1999 5560 (73.5) 4674 (75.3) 66205 (66.2) 87498 (67.9)
2000-2001 6486 (75.7) 5245 (75.4) 73240 (68.1) 94081 (69.8)
2002-2003 7465 (77.6) 6074 (78.3) 80892 (72.2) 103264 (74.1)
2004-2005 6759 (80.9) 5869 (81.9) 74730 (77.0) 95221 (78.9)
2007-2008 6521 (83.6) 5826 (84.6) 72270 (82.3) 93147 (84.2)
2009-2010 6791 (86.3) 5887 (87.0) 66669 (84.7) 88275 (86.5)
Percutaneous coronary intervention (PCI), number (%)
Number (%) who underwent the procedure within 30 days of index AMI admissiona
1992-1993 1394 (8.6) 1243 (10.4) 28013 (12.8) 36743 (16.1)
1994-1995 2009 (11.3) 1768 (13.7) 36406 (16.0) 47057 (19.8)
1996-1997 2483 (13.4) 2120 (15.9) 42885 (18.7) 53486 (22.7)
1998-1999 2861 (14.6) 2335 (17.7) 47506 (21.0) 58746 (25.9)
2000-2001 3398 (16.1) 3019 (21.4) 53981 (23.3) 66189 (29.2)
2002-2003 4134 (18.9) 3633 (24.9) 59331 (26.0) 73620 (32.9)
2004-2005 3956 (21.7) 3602 (28.3) 54776 (28.8) 68973 (36.7)
2007-2008 3748 (22.0) 3564 (29.8) 49938 (29.5) 65672 (38.6)
2009-2010 3916 (24.2) 3728 (32.6) 45375 (30.5) 62705 (40.7)
Among those who underwent PCI, number (%) during the index admissionb
1992-1993 857 (61.5) 754 (60.7) 14567 (52.0) 19915 (54.2)
1994-1995 1241 (61.8) 1120 (63.4) 19519 (53.6) 26582 (56.5)
1996-1997 1600 (64.4) 1329 (62.7) 24381 (56.9) 31498 (58.9)
1998-1999 1841 (64.4) 1497 (64.1) 28156 (59.3) 35960 (61.2)
2000-2001 2330 (68.6) 2026 (67.1) 33527 (62.1) 42653 (64.4)
2002-2003 2916 (70.5) 2607 (71.8) 40308 (67.9) 51497 (70.0)
2004-2005 2972 (75.1) 2802 (77.8) 40402 (73.8) 52304 (75.8)
2007-2008 2999 (80.0) 2926 (82.1) 40387 (80.9) 54283 (82.7)
2009-2010 3315 (84.7) 3148 (84.4) 38285 (84.4) 53819 (85.8)
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Table 2 Percentage of black and white men and women who underwent selected procedures within 30 days of admission
for AMI (Continued)
Coronary artery bypass grafting (CABG), number (%)
Number (%) who underwent the procedure within 30 days of index AMI admissiona
1992-1993 1011 (6.2) 919 (7.7) 19058 (8.7) 33508 (14.7)
1994-1995 1277 (7.2) 1254 (9.7) 23047 (10.1) 39739 (16.7)
1996-1997 1453 (7.8) 1402 (10.5) 25006 (10.9) 41789 (17.7)
1998-1999 1483 (7.6) 1329 (10.1) 22626 (10.0) 37796 (16.7)
2000-2001 1603 (7.6) 1461 (10.4) 21567 (9.3) 36690 (16.2)
2002-2003 1569 (7.2) 1547 (10.6) 19654 (8.6) 34226 (15.3)
2004-2005 1160 (6.4) 1250 (9.8) 14560 (7.7) 26342 (14.0)
2007-2008 937 (5.5) 1064 (8.9) 11125 (6.6) 21249 (12.5)
2009-2010 830 (5.1) 954 (8.3) 8806 (5.9) 17773 (11.6)
Among those who underwent CABG, number (%) during the index admissionb
1992-1993 519 (51.3) 435 (47.3) 7747 (40.7) 14152 (42.2)
1994-1995 624 (48.9) 647 (51.6) 9537 (41.4) 17294 (43.5)
1996-1997 713 (49.1) 729 (52.0) 10868 (43.5) 19127 (45.8)
1998-1999 766 (51.7) 703 (52.9) 10541 (46.6) 18400 (48.7)
2000-2001 871 (54.3) 770 (52.7) 10617 (49.2) 18859 (51.4)
2002-2003 913 (58.2) 905 (58.5) 10726 (54.6) 19471 (56.9)
2004-2005 704 (60.7) 787 (63.0) 8822 (60.6) 16693 (63.4)
2007-2008 604 (64.5) 697 (65.5) 7369 (66.2) 14595 (68.7)
2009-2010 565 (68.1) 648 (67.9) 5883 (66.8) 12332 (69.4)
Revascularization (CABG or PCI), number (%)
Number (%) who underwent the procedure within 30 days of index AMI admissiona
1992-1993 2325 (14.3) 2108 (17.6) 45598 (20.8) 67970 (29.7)
1994-1995 3211 (18.1) 2943 (22.8) 57580 (25.3) 84056 (35.4)
1996-1997 3864 (20.8) 3454 (25.9) 66268 (29.0) 92920 (39.4)
1998-1999 4269 (21.8) 3604 (27.4) 68755 (30.3) 94321 (41.6)
2000-2001 4921 (23.3) 4413 (31.3) 74229 (32.0) 100637 (44.4)
2002-2003 5606 (25.6) 5080 (34.8) 77563 (34.0) 105419 (47.1)
2004-2005 5028 (27.5) 4758 (37.3) 68167 (35.9) 93067 (49.6)
2007-2008 4598 (27.0) 4540 (38.0) 59979 (35.4) 84696 (49.8)
2009-2010 4685 (28.9) 4605 (40.2) 53326 (35.9) 78561 (51.0)
Among those who underwent revascularization, number (%) during the index admissionb
1992-1993 1336 (57.5) 1157 (54.9) 21524 (47.2) 32793 (48.3)
1994-1995 1820 (56.7) 1712 (58.2) 28006 (48.6) 42250 (50.3)
1996-1997 2268 (58.7) 2014 (58.3) 34286 (51.7) 49217 (53.0)
1998-1999 2570 (60.2) 2163 (60.0) 37872 (55.1) 53006 (56.2)
2000-2001 3156 (64.1) 2754 (62.4) 43410 (58.5) 60168 (59.8)
2002-2003 3769 (67.2) 3446 (67.8) 50186 (64.7) 69457 (65.9)
2004-2005 3630 (72.2) 3522 (74.0) 48465 (71.1) 67455 (72.5)
2007-2008 3541 (77.0) 3568 (78.6) 47008 (78.4) 67286 (79.4)
2009-2010 3837 (81.9) 3741 (81.2) 43575 (81.7) 64784 (82.5)
aThe denominator is AMI patients in each stratum, that is, black women, black men, white women and white men; bthe denominator is AMI patients who
underwent the respective procedure in each stratum, that is, black women, black men, white women and white men. AMI, acute myocardial infarction; CABG,
coronary artery bypass surgery; PCI, percutaneous coronary intervention.
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Figure 2 Unadjusted utilization of coronary angiography (A), PCI (B) and CABG (C) within 30 days after admission for AMI. Y-axis shows
the unadjusted percentage of Medicare beneficiaries hospitalized with AMI receiving angiography (with or without revascularization) (A), PCI
(B) or CABG (C) within 30 days of admission. AMI, acute myocardial infarction; CABG, coronary artery bypass surgery; PCI, percutaneous coronary
intervention.
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Table 3 Percentagea of black and white men and women who died within 30 days after admission for AMI (unadjusted
estimates)
Black women Black men White women White male
Mortality, number (%)
1992-1993 3311 (20.4) 2145 (17.9) 50641 (23.1) 44578 (19.5)
1994-1995 3492 (19.7) 2189 (17.0) 50269 (22.1) 43655 (18.4)
1996-1997 3512 (18.9) 2139 (16.0) 48151 (21.0) 41907 (17.8)
1998-1999 3761 (19.2) 2213 (16.8) 46539 (20.5) 40065 (17.7)
2000-2001 3952 (18.7) 2361 (16.8) 45521 (19.6) 38349 (16.9)
2002-2003 3847 (17.6) 2396 (16.4) 42912 (18.8) 36805 (16.4)
2004-2005 3122 (17.1) 1921 (15.1) 34193 (18.0) 29289 (15.6)
2007-2008 2751 (16.1) 1790 (15.0) 29842 (17.6) 26226 (15.4)
2009-2010 2768 (17.1) 1751 (15.3) 26994 (18.2) 24889 (16.2)
aThe denominator is number of AMI patients in each stratum (that is, black women, black men, white women and white men) during each two-year period. AMI,
acute myocardial infarction.
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under-diagnosis of AMI in blacks and women in the
pre-hospital setting. Differences in AMI hospitalization
rates by race and sex remained statistically significant in
2009 to 2010 (P <0.001) despite narrowing of the differ-
ences between cohorts over time in analyses adjusted
for age and year (Figure 1A). This implies that only
some racial and sex differences were attributable to age
and period effects, and some disparities still persisted,
although they narrowed in adjusted analyses. Another
study using the CDC data reported that the male–female
ratio for AMI hospitalization rates remained constant at
2:1 from 2000 to 2008 [21].
Second, we found a marked increase in the utilization
of revascularization among all patient cohorts over time.
These results are consistent with prior studies [22].
Interestingly, while disparities in revascularization have
been well documented [27], relatively few studies have
examined whether disparities in revascularization have
declined over time [28]. Peterson et al., using data from
the National Registry of Myocardial Infarction (NRMI)
found evidence that disparities by race and sex in the
use of revascularization procedures did not decline
between 1990 and 2006 [18]. Alternatively, Jha and col-
leagues found evidence that disparities for certain revas-
cularization procedures declined among certain patient
populations between 1992 and 2001 (for example, PCI in
black and white women) but other disparities persisted
(for example, CABG in black and white men) [10]. Our
results extend prior studies by examining a more compre-
hensive list of revascularization procedures over a longer
time period. Our unadjusted analyses showed minimal
reductions in disparities for most procedures and that
disparities between men and women remain particularly
large. Interestingly, in analyses that adjusted for patient
comorbidity and clustering of patients within hospitals [see
Additional file 1], racial disparities appeared small althoughdisparities by patient sex remained significant. The differ-
ences between our unadjusted and adjusted results are
consistent with prior studies that have suggested that many
disparities can be explained by differences in patients’
acuity and comorbidity and also the quality and practice
patterns of the physicians and hospitals where different
patient groups seek care [2,18,29,30].
Third, our findings with regards to mortality are import-
ant and extend prior work. We found that racial dis-
parities in AMI 30-day mortality grew relatively larger in
the early part of the 21st century, but have declined over
the last five years. Alternatively, disparities by patient sex
(higher mortality for both black and white women when
compared to their male counterparts) have declined little
[31]; higher mortality has been reported in younger
(<50 years), but not older women compared to men of the
same age after AMI [32]. Studies have suggested that sex-
based disparities in mortality can be attributed in part to
differences in the receipt of evidence-based treatments
and interventions, but also perhaps to differences in AMI
presentation, severity and age-of-onset [33]. Irrespective
of the exact cause, the sex-based differences in AMI mor-
tality are striking, similar to a previous population-based
Finnish study [34]. In this study including all age groups
comparing 1994 to 1996 to 2000 to 2002 in two registers,
the 28-day case fatality after AMI declined in men from
46.5% to 41.0% in the FINAMI register and from 54.7% to
50.1% in the Finnish National Cardiovascular Disease
Register (CVDR), respectively. The corresponding num-
bers in women decreased from 53.5% to 48.6% in FINAMI
and from 58.9% to 54.6% in CVDR [34]. Another recent
study found that mortality from ischemic heart disease
increased across all ages in adult women whereas the
corresponding increase was blunted at older ages in men
[35], a potential explanation of sex differences in AMI
mortality in our data as well. A Dutch study of 14,434
patients in coronary units from 1985 to 2008 showed no
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http://www.biomedcentral.com/1741-7015/12/190sex difference in adjusted 30-day mortality [36], as well as
a decline in mortality in both men and women over a
24-year period. The differences in country setting,
health care delivery system, patient comorbidity load
and single center versus national data between this previ-
ous study and our study may explain the differences in
findings. Our mortality models were based on models
developed by the US Centers for Medicare and Medicaid
Services and adjusted for hospital clustering and, there-
fore, our confidence in these findings is high.
Our study has several limitations that warrant mention.
First, our analysis was limited to fee-for-service Medicare
beneficiaries and should be extended to other populations
with caution. In particular, it is uncertain whether an
evaluation of a younger non-Medicare population would
yield similar results. Second, our analysis focused ex-
clusively on AMI and we cannot comment on long-term
trends in disparities for other conditions. Third, our ana-
lyses could have been impacted by changes in coding over
time related to either AMI diagnosis or procedures. How-
ever, there is a long history of using Medicare data in the
evaluation of AMI and we are unaware of any coding
changes that would have directly impacted our results.
Fourth, Medicare data may have race misclassification
since this was not self-identified prospectively; however,
this would bias our findings towards null and, therefore,
our findings are conservative. In addition, this is a general
limitation of studies using Medicare data. The impact of
the exclusion of 2006 is unclear; however we have a long-
enough observation period, and a single year is unlikely to
have meaningfully changed the findings. Fifth, the time-
trends analyses for where the procedures were done are
unadjusted (index hospitalization, transfer hospitalization,
or post-discharge within 30 days); it is anticipated that a
reduction in the length of AMI stay over the study period
likely impacted these rates, and, therefore, these should be
interpreted with caution. Lastly, we are unable to account
for patient preferences, which play a role in utilization of
these procedures or physician preferences, or the clinical
information about the appropriateness of the interven-
tional procedures. This is an important aspect of dispar-
ities that needs to be understood; however, this is likely on
the causal pathway and, therefore, not a confounder of the
estimates presented in this study.
Conclusions
In summary, over the past 18 years we observed declines
in hospitalization rates and mortality and increases in re-
vascularization for AMI in the US Medicare population.
We found that disparities by sex and also by race in
hospitalization rates, receipt of revascularization proce-
dures and mortality have persisted over time. Our study
provides evidence of the continued challenge of insuring
equal care to all patient groups.Additional files
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